359 related articles for article (PubMed ID: 20560994)
1. The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease.
Mitchell RA; Herrmann N; Lanctôt KL
CNS Neurosci Ther; 2011 Oct; 17(5):411-27. PubMed ID: 20560994
[TBL] [Abstract][Full Text] [Related]
2. Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease.
Lanari A; Amenta F; Silvestrelli G; Tomassoni D; Parnetti L
Mech Ageing Dev; 2006 Feb; 127(2):158-65. PubMed ID: 16297434
[TBL] [Abstract][Full Text] [Related]
3. Reward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson's disease.
Muhammed K; Manohar S; Ben Yehuda M; Chong TT; Tofaris G; Lennox G; Bogdanovic M; Hu M; Husain M
Brain; 2016 Oct; 139(Pt 10):2706-2721. PubMed ID: 27452600
[TBL] [Abstract][Full Text] [Related]
4. Apathy associated with Alzheimer disease: use of dextroamphetamine challenge.
Lanctôt KL; Herrmann N; Black SE; Ryan M; Rothenburg LS; Liu BA; Busto UE
Am J Geriatr Psychiatry; 2008 Jul; 16(7):551-7. PubMed ID: 18591575
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological Therapy for Apathy in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Sepehry AA; Sarai M; Hsiung GR
Can J Neurol Sci; 2017 May; 44(3):267-275. PubMed ID: 28148339
[TBL] [Abstract][Full Text] [Related]
6. Apathy in Dementia: Systematic Review of Recent Evidence on Pharmacological Treatments.
Harrison F; Aerts L; Brodaty H
Curr Psychiatry Rep; 2016 Nov; 18(11):103. PubMed ID: 27726067
[TBL] [Abstract][Full Text] [Related]
7. A review of neuroimaging findings of apathy in Alzheimer's disease.
Theleritis C; Politis A; Siarkos K; Lyketsos CG
Int Psychogeriatr; 2014 Feb; 26(2):195-207. PubMed ID: 24135083
[TBL] [Abstract][Full Text] [Related]
8. Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate.
van Dyck CH; Arnsten AFT; Padala PR; Brawman-Mintzer O; Lerner AJ; Porsteinsson AP; Scherer RW; Levey AI; Herrmann N; Jamil N; Mintzer JE; Lanctôt KL; Rosenberg PB
Am J Geriatr Psychiatry; 2021 Jan; 29(1):51-62. PubMed ID: 32461027
[TBL] [Abstract][Full Text] [Related]
9. The Efficacy of Sertraline, Escitalopram, and Nicergoline in the Treatment of Depression and Apathy in Alzheimer's Disease: The Okayama Depression and Apathy Project (ODAP).
Takemoto M; Ohta Y; Hishikawa N; Yamashita T; Nomura E; Tsunoda K; Sasaki R; Tadokoro K; Matsumoto N; Omote Y; Abe K
J Alzheimers Dis; 2020; 76(2):769-772. PubMed ID: 32568205
[TBL] [Abstract][Full Text] [Related]
10. Study of behavioral and psychological symptoms of dementia in Taiwan.
Fuh JL
Acta Neurol Taiwan; 2006 Sep; 15(3):154-60. PubMed ID: 16995594
[TBL] [Abstract][Full Text] [Related]
11. Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge.
Herrmann N; Rothenburg LS; Black SE; Ryan M; Liu BA; Busto UE; Lanctôt KL
J Clin Psychopharmacol; 2008 Jun; 28(3):296-301. PubMed ID: 18480686
[TBL] [Abstract][Full Text] [Related]
12. Understanding and managing behavioural symptoms in Alzheimer's disease and related dementias: focus on rivastigmine.
Robert P
Curr Med Res Opin; 2002; 18(3):156-71. PubMed ID: 12094826
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia.
Deardorff WJ; Grossberg GT
Handb Clin Neurol; 2019; 165():5-32. PubMed ID: 31727229
[TBL] [Abstract][Full Text] [Related]
14. Different apathy clinical profile and neural correlates in behavioral variant frontotemporal dementia and Alzheimer's disease.
Fernández-Matarrubia M; Matías-Guiu JA; Cabrera-Martín MN; Moreno-Ramos T; Valles-Salgado M; Carreras JL; Matías-Guiu J
Int J Geriatr Psychiatry; 2018 Jan; 33(1):141-150. PubMed ID: 28240379
[TBL] [Abstract][Full Text] [Related]
15. Trial design innovations: Clinical trials for treatment of neuropsychiatric symptoms in Alzheimer's Disease.
Cummings J; Zhong K
Clin Pharmacol Ther; 2015 Nov; 98(5):483-5. PubMed ID: 26206713
[TBL] [Abstract][Full Text] [Related]
16. Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer's type.
Pinto T; Lanctôt KL; Herrmann N
Ageing Res Rev; 2011 Sep; 10(4):404-12. PubMed ID: 21292041
[TBL] [Abstract][Full Text] [Related]
17. The role of norepinephrine in the behavioral and psychological symptoms of dementia.
Herrmann N; Lanctôt KL; Khan LR
J Neuropsychiatry Clin Neurosci; 2004; 16(3):261-76. PubMed ID: 15377733
[TBL] [Abstract][Full Text] [Related]
18. Closing-in is related to apathy in Alzheimer's disease patients.
Grossi D; de Lucia N; Trojano L
J Alzheimers Dis; 2015; 43(3):849-55. PubMed ID: 25125462
[TBL] [Abstract][Full Text] [Related]
19. The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial.
Carotenuto A; Rea R; Traini E; Fasanaro AM; Ricci G; Manzo V; Amenta F
J Alzheimers Dis; 2017; 56(2):805-815. PubMed ID: 28035924
[TBL] [Abstract][Full Text] [Related]
20. In vivo MRI Structural and PET Metabolic Connectivity Study of Dopamine Pathways in Alzheimer's Disease.
Iaccarino L; Sala A; Caminiti SP; Presotto L; Perani D;
J Alzheimers Dis; 2020; 75(3):1003-1016. PubMed ID: 32390614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
